ClinicalTrials.Veeva

Menu

Identification of Genetic Polymorphism Related to Acute Kidney Injury After Liver Transplantation Through Genome-wide Association Study (GWAS) in Korean Population

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

The Recipients Undergoing Liver Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT03344380
4-2017-0888

Details and patient eligibility

About

Some of the liver transplantation recipients experience postoperative acute kidney injury due to various causes including genetic factors. Prevention of postoperative acute kidney injury is essential for postoperative care in liver transplantation recipients. The aim of this study is to investigate the relationship between gene polymorphisms and the occurrence of acute kidney injury after liver transplantation by performing genome-wide association study (GWAS).

Enrollment

330 estimated patients

Sex

All

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adult patients scheduled for liver transplantation

Exclusion criteria

  1. Patients on dialysis
  2. patients not able to read, or understand the consent form
  3. ethnicity, other than asian
  4. patients refusal

Trial design

330 participants in 2 patient groups

Prospective cohort
Description:
Adult patients undergoing liver transplantation will be included and followed up during the first 72 hours post-liver transplantation in order to confirm the development of acute kidney injury. The patients will be divided into two groups (AKI group vs. non-AKI group) according to the development of acute kidney injury. The GWAS will be performed with the blood obtained from enrolled patients.
Retrospective cohort
Description:
In previous study performed in adult patients undergoing liver transplantation (NCT02489474, 4-2015-0411), we enrolled patients and collected data regarding the development of acute kidney injury during the first 72 hours post-liver transplantation. Among these patients enrolled in this previous study, only patients who agreed to additional use of the blood sample for research purposes will be included in the present study. The GWAS will be performed with the blood obtained from enrolled patients.

Trial contacts and locations

1

Loading...

Central trial contact

Seung Ho Choi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems